Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Placebo-Controlled Phase 1 Clinical Trial to Evaluate the Safety, Tolerability, and Pharmacokinetic Characteristics of Single and Multiple Inhaled Doses of ICF001 Dry Powder in Healthy Adult Participants

NCT07804628 is registered in ClinicalTrials.gov with VIVID CLINICAL SERVICES PTY LTD as lead sponsor.

NCT NCT07804628
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07804628 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Placebo-Controlled Phase 1 Clinical Trial to Evaluate the Safety, Tolerability, and Pharmacokinetic Characteristics of Single and Multiple Inhaled Doses of ICF001 Dry Powder in Healthy Adult Participants
Lead sponsor
VIVID CLINICAL SERVICES PTY LTD
Phase
Phase 1
Overall status
Not yet recruiting
Start date
September 30, 2026
Completion date
August 26, 2027
Enrollment
72 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy volunteers